| Literature DB >> 31923252 |
A M Abdelatty1, O A M Badr2, S A Mohamed2, M S Khattab3, Sh M Dessouki4, O A A Farid5, A A Elolimy6,7,8, O G Sakr4, M A Elhady9, G Mehesen4, M Bionaz10.
Abstract
Conjugated linoleic acid (CLA) is known for its multiple benefits including improvement of growth, increasing lean mass, and anti-carcinogenic effects. However, when used in long-term supplementations CLA does not improve semen parameters in boar and bull and reduces fertility in Japanese quails. The content of unsaturated fatty acids in dietary lipids plays a significant role in spermatogenesis owning the high proportion of unsaturated fatty acids in plasma membrane of sperms. Whether CLA plays a role in testicular tissue and epididymal fat is still unknown. Therefore, in this study we hypothesize that long-term supplementation of equal proportion of CLA isomer mix (c9,t11-CLA and t10,c12- CLA) in rabbit bucks might alter male reproductive potentials. Twelve V-Line weaned male rabbits were used in 26 weeks trial, rabbits were individually raised and randomly allocated into three dietary groups. Control group (CON) received a basal diet, a group received 0.5% CLA (CLA 0.5%), and a group received 1% CLA (CLA 1%). Rabbits were euthanized at the end of the trial and several parameters were evaluated related to growth, semen quality, and testicular and epididymal tissue histopathology and transcriptome. The long-term supplementation of CLA increased feed intake by 5% and body weight by 2-3%. CLA 1% decreased sperm progressive motility. In testicular tissue L-carnitine and α-tocopherol were decreased by CLA supplementation. In epididymal fat, CLA tended to decrease concentration of polyunsaturated fatty acids, the expression of SCD5 gene was upregulated by CLA 1% and CASP3 gene was upregulated by CLA 0.5%. Transcription of PPARG was downregulated by CLA. Feeding 1% CLA also decreased testicular epithelial thickness. Long-term supplementation of CLA modestly enhanced male rabbit growth, but negatively impacted male reproduction, especially at high dose of CLA.Entities:
Year: 2020 PMID: 31923252 PMCID: PMC6953797 DOI: 10.1371/journal.pone.0226070
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Diet ingredients.
| Ingredient | (g/kg) |
|---|---|
| Barley | 230 |
| Soybean meal (44%) | 160 |
| Clover hay | 300 |
| Wheat Bran | 263 |
| Molasses | 30 |
| Limestone | 10 |
| Sodium Chloride | 4 |
| Premix | 3 |
| Oleic acid | Variable |
1diet was formulated to provide 2500 Kcal digestible energy/kg diet according to rabbit NRC, 1977.
2The premix provides the following (per kg diet): 15,000 IU of Vit. A; 100 mg Vit. E; 21 mg Vit. K3; 10 mg Vit. B1; 40 mg Vit. B2; 15 mg Vit. B6; 0.1 mg Vit. B12; 200 mg Niacin; 100 mg Pantothenic acid; 0.5 mg Biotin; 10 mg Folic acid; 500 mg Choline Chloride; 450 mg Zn; 600 mg Mn; 0.3 mg Fe; 50 mg Cu; 250 mg I.
3Oleic acid was added at a rate of 1% on the control group diet (CON), and 0.5% in the CLA 0.5% group diet.
4Dietary CLA (Conjugated linoleic acid) was added at a dose of 0.5% in the CLA 0.5% diet and 1% in the CLA 1% diet.
Gene names, primer sequences, accession#, and product size of the used genes.
| Gene | Accession # | Primers sequences (5’→3’) | bp | Reference |
|---|---|---|---|---|
| XM_008272555 | 100 | Designed | ||
| XM_008257787 | 100 | Designed | ||
| XM_008267147 | 100 | [ | ||
| XM_008267676.2 | 101 | Designed | ||
| NM_001082148.1 | 102 | Designed | ||
| XM_002710655.3 | 100 | Designed | ||
| NM_001177330.1 | 100 | Designed | ||
| XM_008252361.2 | 113 | Designed | ||
| XM_008261439.2 | 186 | Designed | ||
| NM_001082117.1 | 110 | Designed | ||
| NM_001085444.1 | 94 | Designed |
1UXT, ubiquitously-expressed, prefoldin-like chaperone; RPS15A, Ribosomal Protein S15a; HPRT1A, Hypoxanthine phosphoribosyl transferase 1; SCD5, Stearoyl-CoA desaturase 5;PPARG, Peroxisome Proliferator Activated Receptor gamma; FABP4, Fatty Acid Binding Protein 4; LPL, lipoprotein lipase; BAX, BCL2 Associated X; BCL2, B-cell lymphoma 2; CASP3, Caspase 3; GPX1, Glutathione Peroxidase 1.
2Underline denotes exon-exon junction.
3Product size; base pair.
Chemical composition of the experimental diets (g/kg DM).
| Item (%) | CON | CLA 0.5% | CLA 1% |
|---|---|---|---|
| Dry matter | 911.70 | 915.00 | 915.90 |
| Crude protein | 186.20 | 183.80 | 183.30 |
| Crude fat | 43.40 | 41.30 | 41.00 |
| Ash | 135.2 | 130.00 | 129.40 |
| Crude fiber | 154.40 | 147.50 | 145.50 |
1Control diet supplemented with 1% oleic acid.
2Diet supplemented with 0.5% CLA+0.5% oleic acid.
3Diet supplemented with 1% CLA.
Effect of long term dietary CLA supplementation on sperm kinetics.
| Item | CON | CLA 0.5% | CLA 1% | SEM | |
|---|---|---|---|---|---|
| Motility, % | 79.10 | 84.65 | 79.57 | 1.62 | 0.07 |
| Progressive motility, % | 60.52a | 65.82a | 52.30b | 1.78 | <0.01 |
| DAP, μm | 28.81a | 29.70a | 26.86b | 0.63 | 0.04 |
| DCL, μm | 58.93 | 57.77 | 55.35 | 2.04 | 0.39 |
| DSL, μm | 22.27ab | 23.30a | 21.05b | 0.52 | 0.05 |
| VAP, μm/s | 65.21 | 67.58 | 62.74 | 2.02 | 0.25 |
| VCL, μm/s | 132.51 | 130.83 | 125.14 | 4.73 | 0.45 |
| VSL, μm/s | 50.55 | 53.16 | 48.73 | 1.44 | 0.13 |
| STR,% | 0.77 | 0.77 | 0.77 | 0.01 | 0.97 |
| LIN,% | 0.38 | 0.40 | 0.40 | 0.01 | 0.54 |
| WOB,% | 0.49 | 0.51 | 0.51 | 0.01 | 0.29 |
| ALH, μm | 4.78 | 4.75 | 4.77 | 0.17 | 0.99 |
| BCF, Hz | 31.14a | 31.05a | 29.20b | 0.52 | 0.05 |
1Values are least square mean, n = 4 samples/group, semen was collected twice/week for 7 successive weeks
Control group receiving basal diet supplemented with 1% oleic acid
Group receiving diet supplemented with 0.5% CLA and 0.5% Oleic acid
Group receiving diet supplemented with 1% CLA
Distance average path
distance curved line
distance straight line
velocity average path
velocity curved line
velocity straight line
straightness track
linearity = VSL/VCL
wobble = VAP/VCL
amplitude of lateral head displacement
beat cross frequency.
Different superscript letters denote P ≤ 0.05 between treatments.
Effect of long term dietary CLA supplementation on fatty acid profile and desaturation indices of epididymal fat.
| Fatty acid, (mg/g tissue) | CON | CLA 0.5% | CLA 1% | SEM | |
|---|---|---|---|---|---|
| C10:0 | 0.60ab | 0.64a | 0.53b | 0.03 | 0.03 |
| C12:0 | 0.22b | 0.27a | 0.22b | 0.01 | 0.02 |
| C14:0 | 33.09b | 36.27a | 30.07c | 0.75 | <0.01 |
| C16:0 | 279.95 | 272.46 | 257.90 | 16.48 | 0.64 |
| C16:1 | 36.35 | 34.87 | 32.37 | 1.75 | 0.31 |
| C18:0 | 40.71 | 39.83 | 33.68 | 2.50 | 0.15 |
| C18:1 | 67.70 | 65.20 | 61.68 | 3.72 | 0.54 |
| C18:3 | 242.11 | 242.71 | 196.22 | 15.22 | 0.10 |
| C20:0 | 1.22 | 1.17 | 1.07 | 0.07 | 0.31 |
| C20:1 | 3.16a | 3.01a | 2.61b | 0.13 | 0.04 |
| C20:2 | 2.47 | 2.29 | 2.24 | 0.13 | 0.45 |
| C20:4 | 2.14 | 2.15 | 1.78 | 0.12 | 0.10 |
| Σ SFA | 355.80 | 350.64 | 323.46 | 15.87 | 0.35 |
| Σ MUFA | 107.21 | 103.08 | 96.66 | 4.00 | 0.23 |
| Σ PUFA | 246.72 | 247.14 | 200.23 | 15.12 | 0.09 |
| Σ Fatty acids | 709.73a | 670.79b | 620.36c | 8.54 | <0.01 |
| Elongase | 0.15 | 0.15 | 0.13 | 0.01 | 0.62 |
| Δ 9 desaturase (16) | 10.66 | 11.40 | 11.14 | 0.50 | 0.55 |
| Δ 9 desaturase (18) | 62.44 | 61.93 | 64.76 | 2.10 | 0.61 |
| Δ 9desaturase (c16+18) | 22.90 | 24.41 | 24.37 | 1.08 | 0.53 |
1Values are least square mean, n = 4 samples/group.
2Control group receiving basal diet supplemented with 1% oleic acid to balance for energy.
3Group receiving diet supplemented with 0.5% CLA and 0.5% Oleic acid.
4Group receiving diet supplemented with 1% CLA.
5 Saturated fatty acids.
6 Monounsaturated fatty acids.
7 Poly unsaturated fatty acids.
8 Elongase = C18:0/C16:0.
9 Δ9 desaturase (16) = [C16:1/(C16:1 + C16:0)]*100.
10 Δ9 desaturase (18) = [C18:1/(C18:1 + C18:0)]*100.
11 Δ9 desaturase (16 18) = [(C16:1 + C18:1)/(C16:1 + C16:0 + C18:1 + C18:0)]*100.
Different superscript letters denote P ≤ 0.05 between treatments.